Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The color(s) dark blue, orange, light blue, gray and white is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of stylized word EYSUVIS in dark blue, above the SU is a dark blue eye shaped design intersecting with a tear drop, the
intersection with the eye drop and tear drop is orange, intersecting the tear drop are three straight lines in white that turn gray outside of the design.
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
860 x 288
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Kala Pharmaceuticals, Inc.
INTERNAL ADDRESS
Suite 120
*STREET
490 Arsenal Way
*CITY
Watertown
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02472
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; topical ophthalmic
pharmaceutical preparations; topical ophthalmic pharmaceutical preparations for the relief of the signs and symptoms of dry eye disease
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88708726
Filing Date:11/27/2019
To the Commissioner for Trademarks:
MARK: (Stylized and/or Design, see mark) The color(s) dark blue, orange, light blue, gray and white is/are claimed as a feature of the
mark. The mark consists of stylized word EYSUVIS in dark blue, above the SU is a dark blue eye shaped design intersecting with a tear drop, the intersection with the eye drop and tear drop is orange,
intersecting the tear drop are three straight lines in white that turn gray outside of the design.
The applicant, Kala Pharmaceuticals, Inc., a corporation of Delaware, having an address of
Suite 120
490 Arsenal Way
Watertown, Massachusetts 02472
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: pharmaceutical preparations and substances for the treatment of ophthalmological and ocular diseases and disorders; topical ophthalmic pharmaceutical preparations;
topical ophthalmic pharmaceutical preparations for the relief of the signs and symptoms of dry eye disease
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant hereby appoints Louis C. Cullman. Other appointed attorneys are Alexis C. Douglas. Louis C. Cullman of K & L Gates LLP, is a member of the XX bar, admitted to the bar in XXXX,
bar membership no. XXX, and the attorney(s) is located at
12th Floor
1 Park Plaza
Irvine, California 92614
United States
OCTrademarks@klgates.com (authorized).
The attorney docket/reference number is 1959057.0039.
Louis C. Cullman submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Email Authorization: I authorize the USPTO to send email correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the
email address provided in this application. I understand that a valid email address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Booyong S. Lim/ Date: 11/27/2019
Signatory's Name: Booyong S. Lim
Signatory's Position: Associate General Counse, IP Counsel
Payment Sale Number: 88708726
Payment Accounting Date: 11/27/2019
Serial Number: 88708726
Internet Transmission Date: Wed Nov 27 11:55:26 EST 2019
TEAS Stamp: USPTO/BAS-XXX.XXX.XX.X-20191127115526401
597-88708726-700e7e7fa03490dea92fc3e94fd
8807cf34337bc9bd5fafb813b3bc1b97fbb7d11-
DA-55264452-20191127110849676872